132 related articles for article (PubMed ID: 11265778)
1. Tumor-dendritic cell fusion technology and immunotherapy strategies.
Shu S; Cohen P
J Immunother; 2001; 24(2):99-100. PubMed ID: 11265778
[No Abstract] [Full Text] [Related]
2. Cell fusion: from hybridoma to dendritic cell-based vaccine.
Gong J; Koido S; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-based cancer therapy.
Conrad C; Nestle FO
Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy. Fusion induces tumour rejection.
Hart I; Colaco C
Nature; 1997 Aug; 388(6643):626-7. PubMed ID: 9262393
[No Abstract] [Full Text] [Related]
6. The therapeutic role of dendritic cells in cancer immunotherapy.
Lemoli RM; Curti A; Fogli M; Ferri E; Baccarani M
Haematologica; 2002 Aug; 87(8 Suppl):62-6. PubMed ID: 12412393
[No Abstract] [Full Text] [Related]
7. Dendritic cell immunotherapy for the treatment of neoplastic disease.
Decker WK; Xing D; Shpall EJ
Biol Blood Marrow Transplant; 2006 Feb; 12(2):113-25. PubMed ID: 16443510
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-derived dendritic cells: a promising armament for immunotherapy in human malignancies.
Yi Q; Kwak LW
Clin Cancer Res; 2005 Feb; 11(3):966-7. PubMed ID: 15709160
[No Abstract] [Full Text] [Related]
9. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Weise JB; Maune S; Görögh T; Kabelitz D; Arnold N; Pfisterer J; Hilpert F; Heiser A
Auris Nasus Larynx; 2004 Jun; 31(2):149-53. PubMed ID: 15121224
[TBL] [Abstract][Full Text] [Related]
10. Tumor-dendritic cell fusion as a basis for cancer immunotherapy.
Lee WT; Shimizu K; Kuriyama H; Tanaka H; Kjaergaard J; Shu S
Otolaryngol Head Neck Surg; 2005 May; 132(5):755-64. PubMed ID: 15886631
[TBL] [Abstract][Full Text] [Related]
11. Current issues in dendritic cell cancer immunotherapy.
López JA; Hart DN
Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
[TBL] [Abstract][Full Text] [Related]
12. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell immunotherapy: mapping the way.
Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids.
Lee WT; Tamai H; Cohen P; Teker AM; Shu S
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):608-13. PubMed ID: 18559727
[TBL] [Abstract][Full Text] [Related]
15. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
16. [Application of dendritic cells in clinical tumor therapy].
Li Y; Xian LJ
Ai Zheng; 2002 Apr; 21(4):443-6. PubMed ID: 12452029
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells as vectors for immunotherapy of cancer.
Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
[TBL] [Abstract][Full Text] [Related]
19. The hybrid cell vaccination approach to cancer immunotherapy.
Trefzer U; Herberth G; Sterry W; Walden P
Ernst Schering Res Found Workshop; 2000; (30):154-66. PubMed ID: 10943322
[No Abstract] [Full Text] [Related]
20. Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer.
Kao JY; Zhang M; Chen CM; Chen JJ
Immunol Lett; 2005 Nov; 101(2):154-9. PubMed ID: 15993950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
